Molecular Cell 'Under Review': What Each Status Means and When to Expect a Decision

Before the paper reaches external reviewers, a Cell Press consulting editor at Molecular Cell evaluates whether the mechanistic claim warrants the depth of review Molecular Cell readers expect. About 60 percent of submissions are returned at this stage within 1 to 2 weeks. A desk rejection is typically not a quality judgment.

It most often means the consulting editor concluded the mechanism depth is more appropriate for a sister Cell Press title (Cell Reports, Cell Chemical Biology, or Cell Reports Methods) or that the broader cell-biology audience appeal does not justify the Molecular Cell page-count investment.

The Cell Press editorial office confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (MIQE for quantitative PCR papers, ARRIVE for animal studies, CONSORT for any clinical-trial component), STAR Methods compliance documentation, cover letter directed to the editor, conflict-of-interest declarations from all authors, and ethics-statement documentation.

The consulting editor reads the paper, evaluates mechanism depth, scope fit, and whether orthogonal-method validation supports the central claim. Most rejections happen here.

In parallel with the consulting editor's primary read, ambiguous-fit papers are discussed at the Cell Press editor meeting where peer consulting editors at sister Cell Press titles weigh in on whether the paper would fit better at Molecular Cell, Cell Reports, or Cell Chemical Biology. This editorial-team discussion runs alongside the desk-screen and adds 3 to 5 days to the front-end visible timeline.

Cell Press consulting editors at Molecular Cell typically invite two to three external reviewers. The recruitment window itself can take 10 to 14 days because reviewers with mechanism-depth expertise are scarce and Cell Press editors are selective about reviewer fit. Reviewer invitations from Cell Press journals are weighted higher than most Elsevier titles in reviewers' personal triage queues, so acceptance rates are above the field average.

Once reviewers agree to review, the typical Molecular Cell peer-review cycle lasts 21 to 35 days. Reviewers are asked to evaluate methodological rigor, mechanism-depth coherence, orthogonal-method validation, and broad-cell-biology audience fit. Reviewer reports for Molecular Cell tend to be thorough; 1500 to 3000 word reports are typical.

After both reports return, the consulting editor synthesizes them and may consult the editor-in-chief for high-priority or contentious papers before issuing a decision. The 4 to 8 week median first-decision time applies to papers that reach external peer review.

• Rejection within 1 to 5 days: Administrative issue or immediate scope mismatch.

• Rejection within 7 to 14 days: Consulting editor desk rejection. The editor concluded the paper would fit better at a sister Cell Press title.

• Still Under Review after 3 weeks: Strong signal. Paper passed the steepest Cell Press filter.

• Still Under Review after 10 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry to molecularcell@cell.com is appropriate.

• Status changes to "Decision Pending": Reports are in; expect a decision within 1 to 2 weeks.

This is the most common anxiety we hear from Molecular Cell authors during the active editorial window. The honest answer: no, 6 weeks at Under Review is the normal middle of the Cell Press distribution. Molecular Cell's 4 to 8 week post-screen window means about half of papers take longer than 6 weeks before a first decision. Most reviewer-driven delays come from reviewer-recruitment timing.

Once a reviewer accepts the assignment, reports typically arrive within 21 to 28 days. If the portal still says Under Review at the 8-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension and the editor granted it. This is normal practice at Cell Press.

The better use of the 6-to-8-week window is to audit the revision package reviewers are likely to request: abstract mechanism claim, first figure logic, STAR Methods completeness, reagent and code availability, and the response-letter skeleton. A status note at 6 weeks rarely changes reviewer behavior, but a prepared response file can shorten a later revision by several days.

If your Molecular Cell paper is rejected after review, the natural cascade depends on what the reviewers and consulting editor cited:

Cell Reports is the most natural Cell Press cascade because Cell Press editors transfer manuscripts directly via the portable peer-review system, preserving reviewer reports for the receiving editor. Cell Reports has a broader cell-biology scope and a slightly lower mechanism-depth bar; papers rejected from Molecular Cell for breadth reasons (e.g., the mechanism is sound but the broader audience appeal is uncertain) often fit Cell Reports cleanly.

The transfer process takes 5 to 10 days because Cell Press carries the reviewer reports across.

The EMBO Journal is the second cascade because its mechanism-depth bar is comparable to Molecular Cell's but its broader-biology audience expectation is somewhat lower. EMBO operates a transparent peer-review system similar to Cell Press's, so reviewer reports translate naturally. EMBO turnaround is typically 6 to 8 weeks for first decision.

Cell Chemical Biology is a narrower cascade option for papers where the mechanism work has a chemical-biology lens (small molecule perturbation, chemoproteomics, activity-based probes) that Molecular Cell editors flagged as a better fit for the sister title.

Cell Press asks reviewers at Molecular Cell to evaluate four things specifically. The table below maps each to actionable preparation.

Across Molecular Cell manuscripts, three patterns generate the most consistent reviewer concerns we see at Molecular Cell.

Single-method mechanism without orthogonal confirmation. When the central mechanistic claim rests on a single experimental approach (e.g., only crystal structure data, or only genetic perturbation, or only chemical-biology probes), Molecular Cell reviewers consistently ask for a second orthogonal validation. The strongest revisions add genetic perturbation to support a biochemical or structural claim, or add structural/biochemical data to support a genetic claim.

Check whether your mechanism has enough orthogonal support →

Narrow model-system framing. When the paper is framed exclusively around one cell type, one organism, or one pathway, broad-cell-biology framing concerns surface from at least one reviewer. The strongest manuscripts anchor the introduction to a broader cell-biology principle and demonstrate the mechanism in at least one orthogonal cellular context.

Check whether your framing reaches a Molecular Cell audience →

Cell Press venue mismatch flagged by reviewers. When reviewers conclude the mechanism work is sound but the broader cell-biology audience appeal is uncertain, they sometimes recommend transfer to Cell Reports. Cell Press editors take this seriously and may suggest transfer even when the paper is technically acceptable for Molecular Cell.

Check whether Molecular Cell or Cell Reports is the better fit →

We have reviewed 50+ manuscripts targeting Molecular Cell, Cell, Cell Reports, Cell Chemical Biology, EMBO Journal, and adjacent molecular-biology venues. Full Manusights reviews include a 60-day money-back guarantee, and we do not train models on your manuscript.

In the 100-manuscript Manusights sample across mechanism-heavy cell-biology targets, Manusights internal analysis identifies five recurring preventable risks before peer review: causal claims built from one method, missing STAR Methods details, model-system framing that does not travel, reagent or code availability gaps, and cascade planning that waits until after rejection. Source limitation: Official guidance explains submission and status workflow, but it cannot diagnose whether your specific abstract, figures, methods, and validation stack will satisfy a Molecular Cell reviewer mix.

This page was created from Cell Press's public author guidance at Cell Press author instructions, Cell Press Editorial Manager documentation, SciRev community-reported review-time data, and Manusights pre-submission review experience with Molecular Cell-targeted manuscripts. Numeric claims about desk-decision and review-time windows are sourced to Cell Press editorial speed metrics.

For the Cell Press molecular-biology landscape beyond Molecular Cell, see Cell Reports (broader scope, faster turnaround, Cell Press portable peer-review transfer from Molecular Cell), Cell Chemical Biology (chemical-biology lens), and Cell Reports Methods (methodology focus). The choice across these titles depends on whether the central contribution is mechanism-depth-with-broad-implications (Molecular Cell), mechanism-with-broader-scope (Cell Reports), or chemical-biology-driven (Cell Chemical Biology).

For technical issues during Cell Press submission, the editorial office at molecularcell@cell.com handles most queries via the manuscript record.

Reviewers at Molecular Cell typically draw from one structural/biochemical mechanism expert and one broader cell-biology specialist. Preparing a response template that addresses both perspectives accelerates revision rounds substantially.

For a pre-upload check of your manuscript against the Molecular Cell mechanism-depth bar before submission, our Molecular Cell pre-submission diagnostic flags the orthogonal-validation gaps and broad-framing weaknesses most likely to surface in reviewer reports.